Gonorrhoea strains across Europe becoming more susceptible to main treatment options
According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010.
31st Congress of IUSTI-Europe on Sexually Transmitted Infections
The 31st IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress will address the broad range of science and clinical practice in the field of sexually transmitted infections.
16th European AIDS Conference
The conference will address long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe
Gonococcal antimicrobial susceptibility surveillance in Europe, 2015
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) follows a decentralised and centralised testing model. In 2015, 24 EU/EEA Member States participated in Euro-GASP, 17 through decentralised testing.
Communicable disease threats report, 30 July - 5 August, week 31
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July – 5 August 2017 and includes updates on hepatitis A, West Nile virus, Vibrio, measles, seasonal influenza, MERS, and Legionnaires' disease.
Vaccination and safe sex: addressing hepatitis A outbreaks among men who have sex with men in Europe
Since June 2016, 16 European countries are experiencing hepatitis A outbreaks with 1 500 reported cases involving three separate clusters that mainly affect men who have sex with men. On the occasion of World Hepatitis Day, ECDC stresses the importance of hepatitis A vaccination and safe sex practices including the use of condoms to avoid new infections. As several EU/EEA countries experience hepatitis A vaccine shortages, targeting of vaccination to groups at higher risk of infection is suggested.